Executive Moves | Healthcare | BioTuesdays by Kilmer Lucas IR

Executive Moves

LeonaBio appoints industry veteran Mark F. Kubic as CBO

LeonaBio (NASDAQ: LONA) has appointed Mark F. Kubic as chief business officer (CBO) to lead the company’s business development strategy and execution. Mr. Kubik served as a strategic consultant to LeonaBio and played a...

February 3, 2026

Executive Moves

STAAR appoints Warren Foust and Deborah Andrews as interim co-CEOs

STAAR Surgical (NASDAQ: STAA) has announced that its board of directors has appointed Warren Foust, president and CEO, and Deborah Andrews, CFO, as interim co-CEOs, effective yesterday. According to STAAR, the board’s...

February 2, 2026

Executive Moves

Carisa Schultz joins Nuwellis as CFO

Nuwellis (NASDAQ: NUWE) has announced the appointment of Carisa Schultz as chief financial officer (CFO), effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership...

January 30, 2026

Executive Moves

AIML names Dr. Paul Dorian MIA and head of medical advisory board

AIML Innovations (CSE: AIML; OTCQB: AIMLF; FWB: 42FB) has announced the appointment of Paul Dorian, MD, MSc, as its medical innovation architect (MIA) and head of the company’s medical advisory board, effective...

January 28, 2026

Executive Moves

Rani appoints Dr. Alireza Javadi as CTO

Rani Therapeutics (NASDAQ: RANI) has announced the promotion of Alireza Javadi, PhD, to chief technical officer. Prior to the promotion to CTO, Dr. Javadi served as Rani’s VP, technical operations, where he was...

January 28, 2026

Executive Moves

Zura names Dr. Sandeep Kulkarni as CEO

Zura Bio (NASDAQ: ZURA) has appointed Sandeep Kulkarni, MD, as chief executive officer (CEO), effective today. Dr. Kulkarni will continue to serve as a director of Zura. He succeeds Kim Davis, JD, who has served as...

January 21, 2026

Executive Moves

MediPharm appoints Greg Hunter interim CEO

MediPharm Labs (TSX: LABS; OTCQB: MEDIF; FSE: MLZ) has announced that its CEO, David Pidduck, will step down from his role as of January 23, 2026, and that Greg Hunter, the company’s CFO, has been appointed interim CEO...

January 19, 2026

Executive Moves

Arch names Dr. Patrick Vink as chairman of BOD

Arch Biopartners (TSXV: ARCH; OTCQB: ACHFF) has announced the appointment of Dr. Patrick Vink as chairman of the company’s board of directors (BOD), effective January 15, 2026. Dr. Vink, MD, MBA, has been an advisor to...

January 16, 2026

Executive Moves

Oncolytics names John McAdory EVP strategy and operations; Yujun Wu VP biostatistics

Oncolytics Biotech (NASDAQ: ONCY) has announced the appointments of John McAdory as executive vice president (EVP), strategy and operations, and Yujun Wu as vice president (VP), head of biostatistics. According to...

January 14, 2026

Executive Moves

Achieve appoints Dr. Mark Rubenstein as CMO

Achieve Life Sciences (NASDAQ: ACHV) has announced the promotion of Mark Rubenstein, MD, from interim chief medical officer (CMO) to CMO. Dr. Rubinstein brings more than two decades of experience in clinical medicine...

January 12, 2026

Executive Moves

Biodexa appoints Fiona Sharp as CFO and company secretary

Biodexa Pharmaceuticals (NASDAQ: BDRX) has announced the promotion of Fiona Sharp to chief financial officer (CFO) and company secretary—in addition to her election to the board of directors—effective immediately. The...

January 5, 2026

Executive Moves

PureTech appoints Robert Lyne as CEO

PureTech Health (NASDAQ: PRTC; LSE: PRTC) has announced the appointment of Robert Lyne as chief executive officer (CEO), and member of the board of directors, effective immediately. Mr. Lyne has served as interim CEO...

December 18, 2025

Executive Moves

Brooke Story joins PolyPid as chair of the BOD

PolyPid (NASDAQ: PYPD) has announced the appointment of medtech leader Brooke Story as chair of the board of directors (BOD), effective December 11, 2025. Ms. Story brings more than 25 years of leadership experience in...

December 16, 2025

Executive Moves

ENvue appoints David Johnson as chairman

ENvue Medical (NASDAQ: FEED) announced the appointment of David Johnson as chairman of the board. Mr. Johnson is a seasoned healthcare executive and board leader with more than 30 years of experience across the medical...

December 15, 2025

Executive Moves

Cadrenal appoints Dr. Lee Golden to BOD

Cadrenal Therapeutics (NASDAQ: CVKD) has announced the appointment of Lee Scott Golden, MD, to its board of directors (BOD) as an independent director, effective immediately. Dr. Golden currently serves as EVP and CMO...

December 1, 2025

Executive Moves

Dr. Mark Jaroszeski joins Aspire’s scientific team

Aspire Biopharma (NASDAQ: ASBP) has announced the addition of tenured professor, department of medical engineering, University of South Florida, Mark J. Jaroszeski, PhD, to its scientific team. Dr. Jaroszeski is a...

November 26, 2025

Executive Moves

Joe Dawson joins Rockwell’s BOD

Rockwell Medical (NASDAQ: RMTI) has announced the appointment of Joe Dawson to its board of directors (BOD), and the resignation of Andrea Heslin Smiley from its BOD. Mr. Dawson brings more than 25 years of experience...

November 18, 2025

Executive Moves

Cibus elects Craig Wichner to BOD

Cibus (NASDAQ: CBUS) has announced the election of Craig Wichner to its Board of Directors (BOD) and the board’s strategy committee. “Craig brings an exceptional combination of financial acumen, strategic discipline...

November 11, 2025

Executive Moves

Accomplished industry veteran, Satrajit Misra, joins QTI as CCO

QT Imaging Holdings (OTCQB: QTIH) has announced the appointment of Satrajit Misra, as Chief Commercial Officer (CCO). Mr. Misra’s appointment underscores QT Imaging’s (QTI) commitment to innovation, clinical excellence...

November 10, 2025

Executive Moves

Mary-Elizabeth Gifford joins Clearmind as Chief of Global Impact

Clearmind Medicine (NASDAQ: CMND; FSE: CWY0) has announced the appointment of Mary-Elizabeth Gifford as chief of global impact. Prior to joining Clearmind, Gifford served as chief of global impact at Psyence BioMed, a...

October 27, 2025

Executive Moves

Three key appointments strengthen Amphista’s clinical development capabilities

Closely held Amphista Therapeutics has announced the appointments of Dr. Lisa Butler as SVP of clinical operations, Dr. Alexandra Sevko as VP of translational science, and Nicola Lindsay as head of project and portfolio...

October 23, 2025

Executive Moves

Dr. Bali Pulendran joins Candel’s research advisory board

Candel Therapeutics (NASDAQ: CADL) has announced the appointment of internationally recognized expert in systems immunology and vaccinology, Bali Pulendran, PhD, to Candel’s research advisory board. Dr. Pulendran is the...

October 16, 2025

Subscribe